Requirements for claims of favorable effects on serum lipids by oral antidiabetic agents.
Carmena
R
R
Department of Medicine, University of Valencia, Spain.
D001786:Blood Glucose / Q000378:metabolism; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D015507:Drugs, Investigational / Q000592:standards*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications; D007004:Hypoglycemic Agents / Q000592:standards*; D008055:Lipids / Q000097:blood*; D008297:Male
D001786:Blood Glucose; D015507:Drugs, Investigational; D007004:Hypoglycemic Agents; D008055:Lipids